Sanovi, An Ibm Company

Sanovi, An Ibm Company company information, Employees & Contact Information

Gartner Cool Vendor Sanovi, an IBM Company provides business continuity, IT recovery and Cloud migration solutions using its innovative Application Defined Continuity (ADC) technology for workloads across physical, virtual and cloud infrastructures. Sanovi has over 350 customers, including fortune 500 companies, service providers and multi-billion dollar enterprises across vertical industries. Gartner's 2015 Hype Cycle report on BCP/DR calls out Sanovi's software as the recovery management solution for heterogeneous platforms. Sanovi is a Red Herring Global 100 award 2013 winner. Sanovi's offerings include enterprise DRM and cloud continuity software products.

Company Details

Employees
34
Address
Hosur Road, Bangalore,01,india
Phone
781-270-4111
Industry
Software Development
NAICS
Software Publishers
Website
sanovi.com
HQ
Bangalore
Looking for a particular Sanovi, An Ibm Company employee's phone or email?

Sanovi, An Ibm Company Questions

News

Respiratory Syncytial Virus (RSV) - Sanofi

Respiratory Syncytial Virus (RSV) Sanofi

Sanofi: Information concerning the total number of voting rights and shares - July 2025 - GlobeNewswire

Sanofi: Information concerning the total number of voting rights and shares - July 2025 GlobeNewswire

Sanofi expands patient affordability program by offering access to all its insulins for $35 per month in the US - Yahoo Finance

Sanofi expands patient affordability program by offering access to all its insulins for $35 per month in the US Yahoo Finance

Environmental Impact and Healthcare Systems’ Resilience - Sanofi

Environmental Impact and Healthcare Systems’ Resilience Sanofi

Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation - Yahoo Finance

Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation Yahoo Finance

Press release: Online availability of Sanofi’s half-year financial report for 2025 - GlobeNewswire

Press release: Online availability of Sanofi’s half-year financial report for 2025 GlobeNewswire

Sustainability: Building a Healthier World - Sanofi

Sustainability: Building a Healthier World Sanofi

Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc. - GlobeNewswire

Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc. GlobeNewswire

Press Release: Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1 - Yahoo Finance

Press Release: Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1 Yahoo Finance

Press release: Availability of the Q3 2025 Aide mémoire - GlobeNewswire

Press release: Availability of the Q3 2025 Aide mémoire GlobeNewswire

Press Release: Sanofi announces extension of Blueprint tender offer - Yahoo Finance

Press Release: Sanofi announces extension of Blueprint tender offer Yahoo Finance

Press Release: EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study - Yahoo Finance

Press Release: EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study Yahoo Finance

Press Release: Sanofi’s SAR402663 earns fast track - GlobeNewswire

Press Release: Sanofi’s SAR402663 earns fast track GlobeNewswire

Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia - GlobeNewswire

Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia GlobeNewswire

Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease - Yahoo Finance

Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease Yahoo Finance

Press release: Sanofi successfully prices €1.5 billion bond issue - GlobeNewswire

Press release: Sanofi successfully prices €1.5 billion bond issue GlobeNewswire

Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season - Yahoo Finance

Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season Yahoo Finance

Press Release: Sanofi completes acquisition of Blueprint Medicines - GlobeNewswire

Press Release: Sanofi completes acquisition of Blueprint Medicines GlobeNewswire

Press Release: Sanofi completes acquisition of DR-0201 - GlobeNewswire

Press Release: Sanofi completes acquisition of DR-0201 GlobeNewswire

Press Release: Sanofi to acquire Blueprint Medicines, - GlobeNewswire

Press Release: Sanofi to acquire Blueprint Medicines, GlobeNewswire

Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader - GlobeNewswire

Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader GlobeNewswire

Press Release: Sanofi to acquire Dren Bio’s bispecific - GlobeNewswire

Press Release: Sanofi to acquire Dren Bio’s bispecific GlobeNewswire

Our Global Manufacturing & Supply Network - Sanofi

Our Global Manufacturing & Supply Network Sanofi

Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease - Yahoo Finance

Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease Yahoo Finance

Our Science - Sanofi

Our Science Sanofi

Press Release: Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose - Yahoo Finance

Press Release: Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose Yahoo Finance

Press Release: Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 study - Yahoo Finance

Press Release: Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 study Yahoo Finance

Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia - Yahoo Finance

Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia Yahoo Finance

Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion - Yahoo Finance

Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion Yahoo Finance

Sanofi awards Healthy Futures Solution Fund grants to advance community-led solutions, expand equitable access to care across Massachusetts - Yahoo Finance

Sanofi awards Healthy Futures Solution Fund grants to advance community-led solutions, expand equitable access to care across Massachusetts Yahoo Finance

Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline - GlobeNewswire

Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline GlobeNewswire

A Legacy of Impact - Sanofi

A Legacy of Impact Sanofi

Press Release: Sanofi’s amlitelimab met all primary and key - GlobeNewswire

Press Release: Sanofi’s amlitelimab met all primary and key GlobeNewswire

Press Release: Sanofi’s Sarclisa approved in the EU for the - GlobeNewswire

Press Release: Sanofi’s Sarclisa approved in the EU for the GlobeNewswire

Press Release: Opella reaches study milestone for Cialis - Yahoo Finance

Press Release: Opella reaches study milestone for Cialis Yahoo Finance

Press Release: Sanofi to acquire Vigil Neuroscience, Inc., - GlobeNewswire

Press Release: Sanofi to acquire Vigil Neuroscience, Inc., GlobeNewswire

Press release: Sanofi successfully prices EUR 1.5 billion of bond issue - GlobeNewswire

Press release: Sanofi successfully prices EUR 1.5 billion of bond issue GlobeNewswire

Sanofi's New $1M Community Health Fund Targets 14 Mass. Organizations to Transform Healthcare Access - Stock Titan

Sanofi's New $1M Community Health Fund Targets 14 Mass. Organizations to Transform Healthcare Access Stock Titan

Sanofi's $130M Eco-Smart NJ Campus: Inside the 260,000 sq ft Innovation Hub Housing 2000 Workers - Stock Titan

Sanofi's $130M Eco-Smart NJ Campus: Inside the 260,000 sq ft Innovation Hub Housing 2000 Workers Stock Titan

Press Release: Sanofi initiates phase 3 program for PCV21 - GlobeNewswire

Press Release: Sanofi initiates phase 3 program for PCV21 GlobeNewswire

Press Release: Sanofi’s respiratory pipeline advances with - GlobeNewswire

Press Release: Sanofi’s respiratory pipeline advances with GlobeNewswire

Press Release: Sanofi Enters Next Chapter of Play to Win Strategy - Yahoo Finance

Press Release: Sanofi Enters Next Chapter of Play to Win Strategy Yahoo Finance

Press Release: François-Xavier Roger appointed Chief Financial Officer, member of Sanofi Executive Committee - GlobeNewswire

Press Release: François-Xavier Roger appointed Chief Financial Officer, member of Sanofi Executive Committee GlobeNewswire

Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare - GlobeNewswire

Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare GlobeNewswire

Press Release: Sarclisa approved in the US as the first - GlobeNewswire

Press Release: Sarclisa approved in the US as the first GlobeNewswire

Press Release: Nirsevimab: Sanofi, AstraZeneca and Sobi simplify contractual agreements - Yahoo Finance

Press Release: Nirsevimab: Sanofi, AstraZeneca and Sobi simplify contractual agreements Yahoo Finance

Sanofi Winthrop Industrie - Via Ritzau

Sanofi Winthrop Industrie Via Ritzau

Sanofi Consumer Healthcare North America Earns B Corp Certification in Recognition of Environmental, Social Impact - PR Newswire Canada

Sanofi Consumer Healthcare North America Earns B Corp Certification in Recognition of Environmental, Social Impact PR Newswire Canada

Interested in partnering with Sanofi Pasteur? - Nature

Interested in partnering with Sanofi Pasteur? Nature

Sanofi US Issues Voluntary Nationwide Recall of Auvi-Q® Due to Potential Inaccurate Dosage Delivery - MultiVu

Sanofi US Issues Voluntary Nationwide Recall of Auvi-Q® Due to Potential Inaccurate Dosage Delivery MultiVu

Top Sanovi, An Ibm Company Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant